Anonymous
Guest
Anonymous
Guest
TheGenoptix hematopathology business IS an established lab (that is why Novartis bought them), larger than most of the competition. Also Flow, molecular, cytogenetics/FISH are linked together very closely and one component cannot be spun off/sold....Novartis is leveraging the established lab concept and upgrading it to an FDA compliant lab for their pipeline of companion diagnostics....I think it is a great business model
I said all of the commercial business. Not just flow. What happened to smith-Kline Labs, what happened to corning Labs, what happened to Genzyme Labs (IMPATH), All purchased by biopharma, destroyed and sold!!!
So laaa dee daa daa do dee da da!!